WinstonWınston
Terumo Corporation logo

Terumo Corporation

TRUMY
50
Medical - Instruments & Supplies · Healthcare
Price
$13.96
+0.38 (+2.80%)
Market Cap
$20.59B
Exchange
Other OTC
Winston Score
50
Winston is curious
Mixed quality — meaningful strengths and weaknesses.

Share count falling — buybacks

2.5% over 4y

The company has reduced its share count over this period, returning value to shareholders through buybacks.

Diluted shares outstanding: 1.51B (2022) → 1.48B (2026)

Terumo Corporation is a Japanese medical device company that makes equipment used inside hospitals and clinics. Its main products include blood bags, syringes, catheters, and devices used in heart surgeries and blood vessel procedures. Terumo sells to hospitals, blood banks, and healthcare systems around the world, and it is one of Japan's largest medical device makers.

Terumo earns money by selling its medical products directly to healthcare providers and through long-term supply relationships with hospitals. The company operates globally, with significant revenue coming from Japan, the United States, Europe, and Asia. Its moat comes from strong regulatory approvals, trusted brand relationships with hospitals, and specialized manufacturing know-how that takes years to replicate. The key growth driver is expanding its cardiovascular and interventional device business, particularly in the U.S. and emerging markets, though currency fluctuations and pricing pressure from hospital procurement systems remain ongoing risks.

Winston Score History

Growth Profile

When traditional metrics don't capture the full picture, these are the signals growth stock investors use instead.

Revenue Growth

+15.9% YoY

YoY Growth Rate

Steady revenue growth

EPS Growth

+41.2% YoY

YoY Growth Rate

EPS growth accelerating

R&D Spend

$0/ year

0.0% of revenue

Below sector average (18%)

Research and development spending

Insider Activity

2.0%ownership

Relatively low insider ownership

Cash Position

Cash flow positive

$348.6B cash & investments

Quarterly Free Cash Flow

↑ Burn rate improving

Company generates more cash than it spends — no dilution risk from fundraising

Growth + cash flow

Terumo Corporation is a rare growth stock that's already generating positive cash flow while growing at 16%. The Winston Score doesn't fully credit this transition from "burner" to "earner."

The Winston Score above measures business quality today. Growth stocks often score lower because they invest in the future rather than maximising current profits. These metrics show what matters most for evaluating that future.

Score breakdown

Every number that matters to educated investors.

Each metric is explained in plain language so you know exactly what you're looking at. Start your free trial now.

Quality

Gross Margin
49.6%
Healthy — 49.6% gross margin
Operating Margin
11.4%
Modest — 11.4% operating margin
ROCE
1.8%
Weak — 1.8% return on capital

ROIC between 0% and 5%. They earn a few cents back per dollar invested in the business.

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Growth

Sales YoY
+13.7%
Fast-growing sales (13.7% YoY)
EPS YoY
-15.5%
Earnings shrinking (-15.5% YoY)

Earnings per share down more than 10%. Either a bad year, or a real decline.

EPS Consistency
2/8 quarters
Earnings rarely grow — volatile business

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Cash Flow

Cash Conversion
236%
Turns 236% of profit into real cash
FCF Margin
15.1%
Converts sales into free cash efficiently (15.1%)

FCF margin between 10% and 20%. Every $100 in sales becomes $10 to $20 in real cash.

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Stability

Debt / Equity
0.24
Conservative — low debt load (0.24)
Interest Cover
45.78x
Comfortably covers interest (45.8x)

Interest coverage above 8. Profits cover interest many times over.

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Valuation

P/E Ratio (TTM)
0.2x
Attractive valuation — P/E 0.2

P/E under 10. The price tag is small relative to last year's profit.

P/E vs Forward
+0.1
GROWING
Earnings roughly flat

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Dividends

Dividend Yield
1.29%
Small dividend — 1.29% yield

Modest yield. The bulk of any return needs to come from price appreciation.

Dividend Growth
-38.1%
Dividend cut (-38.1% YoY) — warning sign

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free
🔒 See full fundamentals and if they are improving or declining — click here for your free trial now.
Start free trial